117
Views
0
CrossRef citations to date
0
Altmetric
Nephrology

Effect of preoperative moderate-dose statin and duration on acute kidney injury after cardiac surgery: a retrospective cohort study

ORCID Icon, , , &
Pages 229-238 | Received 23 Jul 2023, Accepted 17 Nov 2023, Published online: 26 Dec 2023

References

  • Vives M, Hernandez A, Parramon F, et al. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2019;12:153–166. doi: 10.2147/IJNRD.S167477.
  • Demirjian S, Bashour CA, Shaw A, et al. Predictive accuracy of a perioperative laboratory test-based prediction model for moderate to severe acute kidney injury after cardiac surgery. JAMA. 2022;327(10):956–964. doi: 10.1001/jama.2022.1751.
  • Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–448. doi: 10.1038/ki.2011.379.
  • See EJ, Jayasinghe K, Glassford N, et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int. 2019;95(1):160–172. doi: 10.1016/j.kint.2018.08.036.
  • Nadim MK, Forni LG, Bihorac A, et al. Cardiac and vascular surgery-associated acute kidney injury: the 20th international consensus conference of the ADQI (acute disease quality initiative) group. J Am Heart Assoc. 2018;7(11):e8834.
  • Sorrentino S, Landmesser U, Baron T. Nonlipid-lowering effects of statins. Curr Treat Options Cardiovasc Med. 2005;7(6):459–466. doi: 10.1007/s11936-005-0031-1.
  • Galyfos G, Sianou A, Filis K. Pleiotropic effects of statins in the perioperative setting. Ann Card Anaesth. 2017;20(Supplement):S43–S48. doi: 10.4103/0971-9784.197796.
  • Singh I, Rajagopalan S, Srinivasan A, et al. Preoperative statin therapy is associated with lower requirement of renal replacement therapy in patients undergoing cardiac surgery: a meta-analysis of observational studies. Interact Cardiovasc Thorac Surg. 2013;17(2):345–352. doi: 10.1093/icvts/ivt178.
  • Virani SS, Nambi V, Polsani VR, et al. Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther. 2010;28(2):80–86. doi: 10.1111/j.1755-5922.2009.00124.x.
  • Tian Y, Li X, Wang Y, et al. Association between preoperative statin exposure and acute kidney injury in adult patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2022;36(4):1014–1020. doi: 10.1053/j.jvca.2021.07.031.
  • Yuan X, Du J, Liu Q, et al. Defining the role of perioperative statin treatment in patients after cardiac surgery: a meta-analysis and systematic review of 20 randomized controlled trials. Int J Cardiol. 2017;228:958–966. doi: 10.1016/j.ijcard.2016.11.116.
  • Putzu A, de Carvalho E Silva CMPD, de Almeida JP, et al. Perioperative statin therapy in cardiac and non-cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care. 2018;8(1):95. doi: 10.1186/s13613-018-0441-3.
  • Wang J, Gu C, Gao M, et al. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31(8):1051–1060. doi: 10.1016/j.cjca.2015.02.034.
  • Li M, Zou H, Xu G. The prevention of statins against AKI and mortality following cardiac surgery: a meta-analysis. Int J Cardiol. 2016;222:260–266. doi: 10.1016/j.ijcard.2016.07.173.
  • Xiong B, Nie D, Cao Y, et al. Preoperative statin treatment for the prevention of acute kidney injury in patients undergoing cardiac surgery: a meta-analysis of randomised controlled trials. Heart Lung Circ. 2017;26(11):1200–1207. doi: 10.1016/j.hlc.2016.11.024.
  • He S, Liu Q, Li H, et al. Role of statins in preventing cardiac surgery-associated acute kidney injury: an updated meta-analysis of randomized controlled trials. Ther Clin Risk Manag. 2018;14:475–482. doi: 10.2147/TCRM.S160298.
  • Zheng Z, Jayaram R, Jiang L, et al. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374(18):1744–1753. doi: 10.1056/NEJMoa1507750.
  • Lee E, Ryan S, Birmingham B, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther. 2005;78(4):330–341. doi: 10.1016/j.clpt.2005.06.013.
  • Birmingham BK, Bujac SR, Elsby R, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in caucasian and Asian subjects residing in the United States. Eur J Clin Pharmacol. 2015;71(3):329–340. doi: 10.1007/s00228-014-1800-0.
  • Zhao S, Yu B, Peng D, et al. The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: results of the CHILLAS trial. Atherosclerosis. 2014;233(2):707–712. doi: 10.1016/j.atherosclerosis.2013.12.003.
  • Alsheikh-Ali AA, Maddukuri PV, Han H, et al. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. J Am Coll Cardiol. 2007;50(5):409–418. doi: 10.1016/j.jacc.2007.02.073.
  • Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults (2016 revised edition). Chin Circ J. 2016;31(10):937–953.
  • von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi: 10.1016/S0140-6736(07)61602-X.
  • Rao C, Zhang H, Gao H, et al. The Chinese cardiac surgery registry: design and data audit. Ann Thorac Surg. 2016;101(4):1514–1520. doi: 10.1016/j.athoracsur.2015.09.038.
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–84. doi: 10.1159/000339789.
  • Knol MJ, VanderWeele TJ, Groenwold RHH, et al. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol. 2011;26(6):433–438. doi: 10.1007/s10654-011-9554-9.
  • Bolesta S, Uhrin LM, Guzek JR. Preoperative statins and acute kidney injury after cardiac surgery: utilization of a consensus definition of acute kidney injury. Ann Pharmacother. 2011;45(1):23–30. doi: 10.1345/aph.1P384.
  • Lombardi R, Ferreiro A. Risk factors profile for acute kidney injury after cardiac surgery is different according to the level of baseline renal function. Ren Fail. 2008;30(2):155–160. doi: 10.1080/08860220701808129.
  • Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119(18):2444–2453. doi: 10.1161/CIRCULATIONAHA.108.800011.
  • Ostermann M, Zarbock A, Goldstein S, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference. JAMA Netw Open. 2020;3(10):e2019209. doi: 10.1001/jamanetworkopen.2020.19209.
  • Lazzareschi D, Mehta RL, Dember LM, et al. Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 kidney disease clinical trialists meeting. Nephrol Dial Transplant. 2023;38(4):834–844. doi: 10.1093/ndt/gfac003.
  • Park J, Lee JH, Kim KA, et al. Effects of preoperative statin on acute kidney injury after off‐pump coronary artery bypass grafting. J Am Heart Assoc. 2019;8(7):e10892.
  • Layton JB, Kshirsagar AV, Simpson RJ, et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013;111(6):823–828. doi: 10.1016/j.amjcard.2012.11.047.
  • Tabata M, Khalpey Z, Pirundini PA, et al. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol. 2007;100(3):442–444. doi: 10.1016/j.amjcard.2007.03.071.
  • Billings FT, Hendricks PA, Schildcrout JS, et al. High-Dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315(9):877–888. doi: 10.1001/jama.2016.0548.
  • Park JH, Shim J, Song J, et al. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42(9):1398–1407. doi: 10.1007/s00134-016-4358-8.
  • Prowle J, Calzavacca P, Licari E, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton). 2012;17(3):215–224. doi: 10.1111/j.1440-1797.2011.01546.x.
  • Board J. Joint british societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100Suppl(2)Suppl 2)::i1.
  • Greenland P, Bonow RO. Interpretation and use of another statin guideline. JAMA Cardiol. 2017;2(1):7–9. doi: 10.1001/jamacardio.2016.4950.
  • Katsiki N, Triposkiadis F, Giannoukas AD, et al. Statin loading in cardiovascular surgery: never too early to treat. Curr Opin Cardiol. 2018;33(4):436–443. doi: 10.1097/HCO.0000000000000519.
  • Chen WT, Krishnan GM, Sood N, et al. Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. J Thorac Cardiovasc Surg. 2010;140(2):364–372. doi: 10.1016/j.jtcvs.2010.02.042.
  • Presta P, Rubino AS, Lucisano G, et al. Preoperative statins improve recovery of renal function but not by an anti-inflammatory effect: observational study in 69 elderly patients undergoing cardiac surgery. Int Urol Nephrol. 2011;43(2):601–609. doi: 10.1007/s11255-011-9956-3.
  • Paraskevas KI, Veith FJ, Liapis CD, et al. Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update. Curr Vasc Pharmacol. 2013;11(1):112–120.
  • Plenge JK, Hernandez TL, Weil KM, et al. Simvastatin lowers C-Reactive protein within 14 days an effect independent of low-density lipoprotein cholesterol reduction. Circulation. 2002;106(12):1447–1452. doi: 10.1161/01.cir.0000029743.68247.31.
  • Shvartz V, Khugaeva E, Kryukov Y, et al. Long-term preoperative atorvastatin or rosuvastatin use in adult patients before CABG does not increase incidence of postoperative acute kidney injury: a propensity score-matched analysis. Pathophysiology. 2022;29(3):354–364. doi: 10.3390/pathophysiology29030027.
  • Astaneh B, Nemati MH, Raeisi SH, et al. The effect of preoperative statins on postoperative mortality, renal, and neurological complications in patients undergoing cardiac surgeries: a retrospective cohort study. J Cardiovasc Surg. 2023;64(1):100–111. doi: 10.23736/S0021-9509.22.12437-7.
  • Nomani H, Mohammadpour AH, Reiner Ž, et al. Statin therapy in post-operative atrial fibrillation: focus on the anti-inflammatory effects. J Cardiovasc Dev Dis. 2021;8(3):24. doi: 10.3390/jcdd8030024.
  • Bronicki RA, Hall M. Cardiopulmonary bypass-induced inflammatory response. Pediatr Crit Care Med. 2016;17(8 Suppl 1):S272–S8. doi: 10.1097/PCC.0000000000000759.
  • Murphy GJ, Lin H, Coward RJ, et al. An initial evaluation of post-cardiopulmonary bypass acute kidney injury in swine. Eur J Cardiothorac Surg. 2009;36(5):849–855. doi: 10.1016/j.ejcts.2009.05.042.
  • Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977–987. doi: 10.1038/nrd1901.
  • Adam O, Neuberger H-R, Böhm M, et al. Prevention of atrial fibrillation with 3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Circulation. 2008;118(12):1285–1293. doi: 10.1161/CIRCULATIONAHA.107.760892.
  • Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-Reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001;286(1):64–70. doi: 10.1001/jama.286.1.64.
  • Peng K, McIlroy DR, Bollen BA, et al. Society of cardiovascular anesthesiologists clinical practice update for management of acute kidney injury associated with cardiac surgery. Anesth Analg. 2022;135(4):744–756. doi: 10.1213/ANE.0000000000006068.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.